NewAmsterdam Pharma Company NV - Warrants (15/11/2027) OverviewNewAmsterdam Pharma Company NV - Warrants (15/11/2027) Total Revenue
Revenue analysis for NAMSW.
Quarterly Revenue
$3.04M
↑ 2.08% YoY
As of Mar 2026
Annual Revenue (TTM)
$22.57M
↓ 52.13% YoY
Trailing 12 months ending Mar 2026
Average Revenue (Comparison Companies)
Total Revenue History
Total Revenue Comparison
Annual Revenue Growth Rate (%)
Annual Revenue Growth (Absolute)